登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002716 证券简称：湖南白银 公告编号：2025-062 湖南白银股份有限公司 第六届董事会第十六次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗漏。 一、会议召开情况 湖南白银股份有限公司（以下简称"公司"）第六届董事会第十六次会议通知于2025年9月15日以电话和 专人送达的方式发出，于9月16日上午9：30分在郴州市苏仙区白露塘镇福城大道1号湖南白银316会议室 以现场与通讯表决的方式召开。会议应出席董事9人，实际出席会议的董事9人。 会议由董事长李光梅主持，公司全体监事、高级管理人员列席会议。本次会议符合《中华人民共和国公 司法》《中华人民共和国证券法》《深圳证券交易所股票上市规则》等有关法律、法规、规章及《公司 章程》的规定。 二、会议审议情况 （一）《关于调整2025年限制性股票激励计划相关事项的议案》 内容：根据公司2025年第一次临时股东大会的授权，董事会对《2025年限制性股票激励计划（草案修订 稿）》（以下简称"《激励计划（草案修订稿）》""激励计划"）的激励对象人数及授予 ...

截至2025年9月11日收盘，咸亨国际（605056）报收于14.05元，较前一交易日上涨0.72%，最新总市值 为57.66亿元。该股当日开盘13.83元，最高14.14元，最低13.72元，成交额达3462.93万元，换手率为 0.61%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 近日，咸亨国际科技股份有限公司发布《2025年限制性股票激励计划（草案）》。根据公告，公司拟实 施2025年限制性股票激励计划，股份来源为公司从二级市场回购的A股普通股，拟授予限制性股票总量 为600.00万股，占公司股本总额的1.46%。激励对象共计174人，包括高级管理人员、核心管理人员及董 事会认为需要激励的其他人员，不包括独立董事、监事及持股5%以上股东。授予价格为7.29元/股。 《咸亨国际：第三届董事会第十九次会议决议公告》 《咸亨国际：第三届监事会第十五次会议决议公告》 《咸亨国际：董事会薪酬与考核委员会关于公司2025年限制性股票激励计划相关事项的核查意 见》 《咸亨国际：2025年限制性股票激励计划激励对象名单》 《咸亨国际： ...

Core Points - The company Baisimei (SZ 300796) announced an incentive plan on September 10, which will grant a total of 116 individuals restricted stock, sourced from shares repurchased in the secondary market [1] - The total number of restricted shares to be granted is up to 5.6 million, representing approximately 1.55% of the company's total share capital of about 361 million shares at the time of the announcement [1] - The grant price for the restricted shares is set at 5.65 yuan per share, allowing recipients to purchase the shares at this price upon meeting vesting conditions, with a maximum validity period of 48 months [1] - For the first half of 2025, Baisimei's revenue composition is entirely from pesticide intermediates and the active ingredient of dimethomorph, indicating a focused business model [1] - As of the report date, Baisimei's market capitalization stands at 3.7 billion yuan [1]

Company Overview - Yuhuan CNC announced an incentive plan granting 1.04 million restricted stocks to 37 individuals, representing 0.67% of the company's total share capital of approximately 156 million shares [1] - The grant price for the restricted stocks is set at 11.46 yuan per share, with a validity period of up to 48 months from the completion of the registration [1] Financial Performance - For the first half of 2025, Yuhuan CNC's revenue composition is as follows: 55.79% from consumer electronics manufacturing, 28.92% from other sectors, 14.55% from automotive parts manufacturing, and 0.74% from the energy and power industry [1] - The current market capitalization of Yuhuan CNC is 3.7 billion yuan [1]

Group 1 - The company has approved the use of idle raised funds not exceeding 90 million yuan to temporarily supplement working capital, with a usage period of no more than 12 months from the board's approval date [2][6][7] - The company has established a special account for raised funds, which will only be used for temporarily supplementing working capital, and has signed a tripartite supervision agreement with the sponsor and the bank [3][5][6] - The company raised a total of 1,075,950,160 yuan from its initial public offering, with a net amount of 978,057,381.28 yuan after deducting issuance costs [2][4] Group 2 - The company will have 15,639,463 shares listed for circulation on September 15, 2025, following the issuance of shares to specific investors [15][16] - The total share capital of the company will increase to 277,885,415 shares after the issuance, and further to 333,462,498 shares after a capital reserve transfer [17][18] - The independent financial advisor has confirmed that the shareholders of the restricted shares have complied with their commitments, and the listing of these shares meets regulatory requirements [19][20] Group 3 - The company will participate in a collective performance briefing for the medical device industry on September 17, 2025, to communicate its half-year results and address investor questions [33][34] - Investors can submit questions for the briefing from September 10 to September 16, 2025, and the company will respond to commonly asked questions during the event [35][36]

Core Viewpoint - Midea Group has announced the repurchase and cancellation of certain restricted stock incentives from the 2022 and 2023 stock incentive plans due to reasons such as employee departures and performance evaluations not meeting standards [1][10][22] Summary by Sections 2022 Restricted Stock Incentive Plan - The plan initially aimed to grant 12,630,000 shares to 199 incentive targets at a price of 28.14 yuan per share, which was later adjusted to 26.47 yuan per share [2][3] - After adjustments for departures, the actual number of shares granted was reduced to 12,152,500 shares for 191 targets [2] - A total of 270,000 shares were repurchased and canceled due to 10 targets leaving or changing positions [3][4] - The repurchase price was adjusted from 26.47 yuan to 23.97 yuan per share [4][16] - Further repurchases occurred, totaling 1,052,500 shares for 24 targets due to similar reasons [4][5] - The final repurchase price was adjusted to 20.97 yuan per share [5][18] 2023 Restricted Stock Incentive Plan - The plan proposed granting 18,375,000 shares to 416 targets at an initial price of 28.39 yuan per share, later adjusted to 25.89 yuan per share [10][19] - The actual number of shares granted was 18,325,000 shares after one target canceled their subscription [11] - A total of 3,000 shares were repurchased from one target due to a position change [11][12] - The repurchase price was adjusted to 20.97 yuan per share [13][20] - Additional repurchases of 484,358 shares occurred due to various reasons affecting 46 targets [13][21] Impact on Company - The repurchase and cancellation of shares will not materially affect the company's financial status or operational results, nor will it impact the diligence of the management team [22]

Core Viewpoint - The report outlines the implementation of the 2025 Restricted Stock Incentive Plan by Meixin Technology, detailing the adjustments made to the plan and the implications for shareholders and the company's financial performance [1][3][11]. Group 1: Incentive Plan Details - The 2025 Restricted Stock Incentive Plan involves granting restricted stocks to certain employees, including directors and senior management, with specific conditions for lifting the restrictions [1][3]. - The initial number of recipients was adjusted from 55 to 51, and the total number of shares granted was reduced from 800,000 to 769,500 due to voluntary forfeitures by some recipients [7][9]. - The first grant date for the restricted stocks is set for September 4, 2025, with a grant price of 30.63 yuan per share [9][10]. Group 2: Approval and Compliance - The plan has undergone necessary approvals, including board meetings and shareholder meetings, ensuring compliance with relevant laws and regulations [6][11]. - The independent financial advisor confirms that the adjustments and conditions of the incentive plan align with the requirements of the Company Law, Securities Law, and other regulatory guidelines [11]. Group 3: Financial Impact - The implementation of the incentive plan is expected to be accounted for in accordance with relevant accounting standards, with potential impacts on the company's financial status and operating results to be assessed in future audits [9][10].

Core Viewpoint - The legal opinion letter confirms that the 2025 restricted stock incentive plan of Huigreen Ecological Technology Group Co., Ltd. has obtained the necessary approvals and complies with relevant laws and regulations [1][12]. Group 1: Approval and Authorization of the Grant - The company has passed resolutions regarding the 2025 restricted stock incentive plan, including the draft and implementation assessment management measures, and has authorized the board of directors to handle related matters [3][4][5]. - The independent directors have provided independent opinions on the incentive plan, and the supervisory board has conducted a review and issued opinions on the plan [3][4]. Group 2: Adjustment of Grant Price - The board of directors has approved the adjustment of the grant price for the reserved portion of the restricted stock to RMB 4.55 per share, following the company's dividend distribution [6][10]. - The adjustment method for the grant price is based on the dividend amount per share, ensuring compliance with the management regulations [7][10]. Group 3: Grant Date and Conditions - The grant date for the reserved portion of the restricted stock is set for September 4, 2025, as authorized by the shareholders' meeting [9][12]. - The conditions for granting the restricted stock include the absence of adverse audit reports and the eligibility of the incentive objects, which have been verified by the company's legal counsel [9][12]. Group 4: Disclosure of Information - The company is required to disclose relevant documents related to the grant in accordance with the management regulations and will fulfill its ongoing disclosure obligations [11][12].

Core Points - The company has adjusted its 2025 restricted stock incentive plan due to 63 participants voluntarily opting out, reducing the number of incentive targets from 991 to 928 [2][3] - The adjusted grant price for the restricted stock is set at 2.71 RMB per share after accounting for a cash dividend of 0.25 RMB per share [3] - The adjustments made to the incentive plan are deemed compliant with relevant regulations and will not materially affect the company's financial status or operational results [3][5] Summary of Related Sections Approval Procedures - The draft of the 2025 restricted stock incentive plan has been approved by the company's board of directors, supervisory board, and shareholders' meeting [1][2] Reasons for Adjustment - The adjustment was necessary due to the voluntary withdrawal of 63 individuals from the incentive plan, leading to a reduction in both the number of participants and the total number of restricted stocks granted [2] Impact of Adjustments - The changes to the incentive plan, including the adjustment of the grant price and the number of participants, are not expected to have a significant impact on the company's financial condition or operational performance [3] Opinions from Committees - The company's remuneration and assessment committee, as well as the supervisory board, have confirmed that the adjustments comply with the relevant regulations and do not harm the interests of shareholders [3][5] Legal Opinions - Legal counsel has stated that the adjustments to the incentive plan have received the necessary authorizations and approvals, and the company must complete the registration procedures for the grants [5]

Core Viewpoint - The report discusses the independent financial advisory opinion regarding the stock incentive plan of Beijing Huichen Zidao Information Co., Ltd., highlighting the approval process and conditions for granting restricted stocks to certain employees. Summary by Sections 1. Definitions - The document defines key terms related to the stock incentive plan, including "restricted stocks," "incentive objects," and "grant date" [1][2]. 2. Independent Financial Advisor's Opinion - The independent financial advisor assesses the fairness and reasonableness of the stock incentive plan for shareholders and its impact on the company's ongoing operations [3][4]. 3. Approval Process - The stock incentive plan has undergone necessary approval procedures, including resolutions from the board and supervisory committee, with no objections raised during the public notice period [6][7]. 4. Conditions for Granting Restricted Stocks - The granting of restricted stocks is contingent upon meeting specific conditions, including the absence of negative audit opinions and compliance with legal regulations [9][10]. 5. Specifics of the Deferred Grant - The plan includes details about the deferred granting of 100,000 shares to a specific executive due to prior indirect share reductions, with the grant to be reconsidered once conditions are met [7][8]. 6. Financial Impact - The financial advisor recommends that the company account for the costs associated with the stock incentive plan in accordance with relevant accounting standards, noting potential dilution effects [13][14]. 7. Conclusion - The independent financial advisor concludes that the stock incentive plan has received the necessary approvals and adheres to relevant regulations, confirming that the granting conditions are met [14].